Patents by Inventor Wenbin Xue

Wenbin Xue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intestinal bacteria and application thereof
    Patent number: 11484583
    Abstract: Provided is an application of Butyribacter intestini in the treatment and prevention of obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: November 1, 2022
    Assignee: BGI SHENZHEN
    Inventors: Qiang Feng, Wenbin Xue, Yuanqiang Zou, Xiaoping Li, Chuan Liu, Xin Li
  • Biologically pure strain, composition including the same and method for treating ulcerative colitis
    Patent number: 11191790
    Abstract: Provided are a biologically pure Faecalibacterium butyricigenerans strain AF52-21 deposited under CGMCC Accession No. 1.5206 and a composition including the same and a carrier. A method for treating an inflammation-related disease in a subject in need thereof is also provided. The Faecalibacterium butyricigenerans is useful for treating ulcerative colitis and related disorders.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: December 7, 2021
    Assignee: BGI SHENZHEN
    Inventors: Yuanqiang Zou, Wenbin Xue, Liang Xiao, Xiaoping Li, Jinghong Yu, Chuan Liu
  • Intestinal bacteria butyribacterintestini and application thereof
    Patent number: 11033614
    Abstract: Provided is an application of Butyribacter intestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: June 15, 2021
    Assignee: BGI SHENZHEN
    Inventors: Qiang Feng, Wenbin Xue, Yuanqiang Zou, Xiaoping Li, Chuan Liu, Xin Li
  • INTESTINAL BACTERIA BUTYRIBACTERINTESTINI AND APPLICATION THEREOF
    Publication number: 20210170009
    Abstract: Provided is an application of Butyribacter intestini in the treatment and prevention of obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
    Type: Application
    Filed: February 11, 2021
    Publication date: June 10, 2021
    Inventors: Qiang Feng, Wenbin Xue, Yuanqiang Zou, Xiaoping Li, Chuan Liu, Xin Li
  • and application thereof
    Patent number: 10806759
    Abstract: Provided are Christensenella intestinihominis and an application thereof, specifically, use of Christensenella intestinihominis in treating and preventing obesity and related diseases thereof. Also provided are a composition for treating and preventing obesity and related diseases thereof, comprising compositions of drugs, drinks, food, or animal feed, and a method for reducing weight and/or blood lipid.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: October 20, 2020
    Assignee: BGI SHENZHEN
    Inventors: Yuanqiang Zou, Wenbin Xue, Mei Lv, Liang Xiao, Xiaoping Li, Jinghong Yu, Chuan Liu
  • Faecalibacterium longum and application thereof
    Patent number: 10799540
    Abstract: Provided are Faecalibacterium longum and an application thereof, specifically, use of Faecalibacterium longum in treating and preventing diabetes and related diseases thereof. Also provided are a composition for treating and preventing diabetes and related diseases thereof, comprising compositions of drugs, drinks, food, or animal feed, and a method for reducing weight, fasting plasma glucose and/or blood lipid, and improving glucose tolerance.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: October 13, 2020
    Assignee: BGI SHENZHEN
    Inventors: Yuanqiang Zou, Wenbin Xue, Liang Xiao, Chuan Liu
  • CHRISTENSENELLA INTESTINIHOMINIS AND APPLICATION THEREOF
    Publication number: 20190282633
    Abstract: Provided are Christensenella intestinihominis and an application thereof, specifically, use of Christensenella intestinihominis in treating and preventing obesity and related diseases thereof. Also provided are a composition for treating and preventing obesity and related diseases thereof, comprising compositions of drugs, drinks, food, or animal feed, and a method for reducing weight and/or blood lipid.
    Type: Application
    Filed: September 6, 2016
    Publication date: September 19, 2019
    Inventors: Yuanqiang ZOU, Wenbin XUE, Mei LV, Liang XIAO, Xiaoping LI, Jinghong YU, Chuan LIU
  • BIOLOGICALLY PURE FAECALIBACTERIUM BUTYRICIGENERANS STRAIN, COMPOSITION INCLUDING THE SAME AND METHOD FOR TREATING INFLAMMATION-RELATED DISEASE
    Publication number: 20190240265
    Abstract: Provided are a biologically pure Faecalibacterium butyricigenerans strain AF52-21 deposited under CGMCC Accession No. 1.5206 and a composition including the same and a carrier. A method for treating an inflammation-related disease in a subject in need thereof is also provided.
    Type: Application
    Filed: February 8, 2019
    Publication date: August 8, 2019
    Inventors: Yuanqiang ZOU, Wenbin XUE, Liang XIAO, Xiaoping LI, Jinghong YU, Chuan LIU
  • FAECALIBACTERIUM LONGUM AND APPLICATION THEREOF
    Publication number: 20190240264
    Abstract: Provided are Faecalibacterium longum and an application thereof, specifically, use of Faecalibacterium longum in treating and preventing diabetes and related diseases thereof. Also provided are a composition for treating and preventing diabetes and related diseases thereof, comprising compositions of drugs, drinks, food, or animal feed, and a method for reducing weight, fasting plasma glucose and/or blood lipid, and improving glucose tolerance.
    Type: Application
    Filed: September 6, 2016
    Publication date: August 8, 2019
    Inventors: Yuanqiang ZOU, Wenbin XUE, Liang XIAO, Chuan LIU
  • INTESTINAL BACTERIA BUTYRIBACTERINTESTINI AND APPLICATION THEREOF
    Publication number: 20180339034
    Abstract: Provided is an application of Butyribacter intestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
    Type: Application
    Filed: March 21, 2016
    Publication date: November 29, 2018
    Inventors: Qiang Feng, Wenbin Xue, Yuanqiang Zou, Xiaoping Li, Chuan Liu, Xin Li